315 related articles for article (PubMed ID: 1744586)
1. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
[TBL] [Abstract][Full Text] [Related]
2. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
4. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
5. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
Goulder PJ; Brander C; Annamalai K; Mngqundaniso N; Govender U; Tang Y; He S; Hartman KE; O'Callaghan CA; Ogg GS; Altfeld MA; Rosenberg ES; Cao H; Kalams SA; Hammond M; Bunce M; Pelton SI; Burchett SA; McIntosh K; Coovadia HM; Walker BD
J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
[TBL] [Abstract][Full Text] [Related]
7. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
[TBL] [Abstract][Full Text] [Related]
8. Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals.
Klein MR; Veenstra J; Holwerda AM; Roos MT; Gow I; Patou G; Coutinho RA; De Wolf F; Miedema F
AIDS Res Hum Retroviruses; 1997 Mar; 13(5):393-9. PubMed ID: 9075480
[TBL] [Abstract][Full Text] [Related]
9. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.
Johnson RP; Trocha A; Yang L; Mazzara GP; Panicali DL; Buchanan TM; Walker BD
J Immunol; 1991 Sep; 147(5):1512-21. PubMed ID: 1715361
[TBL] [Abstract][Full Text] [Related]
11. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
Klenerman P; Rowland-Jones S; McAdam S; Edwards J; Daenke S; Lalloo D; Köppe B; Rosenberg W; Boyd D; Edwards A
Nature; 1994 Jun; 369(6479):403-7. PubMed ID: 7515165
[TBL] [Abstract][Full Text] [Related]
14. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
Buseyne F; McChesney M; Porrot F; Kovarik S; Guy B; Rivière Y
J Virol; 1993 Feb; 67(2):694-702. PubMed ID: 7678303
[TBL] [Abstract][Full Text] [Related]
15. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
Masemola AM; Mashishi TN; Khoury G; Bredell H; Paximadis M; Mathebula T; Barkhan D; Puren A; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM;
J Immunol; 2004 Oct; 173(7):4607-17. PubMed ID: 15383595
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
Chargelegue D; O'Toole CM; Colvin BT
Clin Exp Immunol; 1993 Sep; 93(3):331-6. PubMed ID: 8370162
[TBL] [Abstract][Full Text] [Related]
17. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT
J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791
[TBL] [Abstract][Full Text] [Related]
18. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
[TBL] [Abstract][Full Text] [Related]
19. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
Ferrari G; King K; Rathbun K; Place CA; Packard MV; Bartlett JA; Bolognesi DP; Weinhold KJ
Clin Exp Immunol; 1995 Aug; 101(2):239-48. PubMed ID: 7544247
[TBL] [Abstract][Full Text] [Related]
20. Association between HIV Type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China.
Wang S; Zhuang Y; Zhai S; Zhao S; Kang W; Li X; Yu XG; Walker BD; Altfeld MA; Sun Y
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):780-7. PubMed ID: 16910834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
